-
Mashup Score: 2
Mitch Shultz, MD, speaks on the capabilities of a cloud-based database system to look at energy-fluid metrics, provide surgeons with the capacity to refine procedures and give patients better outcomes.
Source: Ophthalmology TimesCategories: Latest Headlines, OphthalmologyTweet
-
Mashup Score: 2Case study: Sebaceous gland carcinoma with no eyelid involvement - 3 year(s) ago
Case study looks at a 90-year-old patient with a sebaceous gland carcinoma with corneal and bulbar conjunctival involvement, but the eyelid was spared.
Source: Ophthalmology TimesCategories: Latest Headlines, OphthalmologyTweet
-
Mashup Score: 2
Steven Greenstein, MD, reports on the 10-year postop data from an epi-off corneal collagen cross-linking treatment in keratoconus and ectasia patients.
Source: Ophthalmology TimesCategories: Latest Headlines, OphthalmologyTweet
-
Mashup Score: 2
Hisaharu Suzuki, MD, PhD, provides insight on how a handpiece maintains the anterior chamber stability even when occlusion occurs, suggesting its usefulness for a safe and efficient surgery.
Source: Ophthalmology TimesCategories: Latest Headlines, OphthalmologyTweet
-
Mashup Score: 2Analyzing comparative lens rotations in toric IOL platforms - 3 year(s) ago
Ed Hu, MD, PhD, shares highlights from his paper analyzing three years’ worth of his own postop data on comparative lens rotations in toric IOL platforms.
Source: Ophthalmology TimesCategories: Latest Headlines, OphthalmologyTweet
-
Mashup Score: 15Grail Study shows refractive stability of Juvene IOL - 3 year(s) ago
Eric Donnenfeld, MD, presents results of the year-long Grail Study demonstrating the safety and performance of the Juvene IOL from LensGen Inc.
Source: Ophthalmology TimesCategories: Latest Headlines, OphthalmologyTweet
-
Mashup Score: 2RVL Pharmaceuticals: Shifting toward ocular aesthetics - 3 year(s) ago
COO JD Schaub provides an overview of how RVL Pharmaceuticals has shifted toward becoming an ocular aesthetics company, with the sole purpose to fully focus on UPNEEQ®.
Source: Ophthalmology TimesCategories: Latest Headlines, OphthalmologyTweet
-
Mashup Score: 2Evaluating efficacy, safety of intracameral dexamethasone 9% vs topical regimen for cataract surgery - 3 year(s) ago
Robert Weinstock, MD, discusses the efficacy and safety of intracameral dexamethasone suspension 9% compared to standard of care topical regimen for eyes receiving cataract surgery.
Source: Ophthalmology TimesCategories: Latest Headlines, OphthalmologyTweet-
. @rjweinstockmd discusses the efficacy, safety of intracameral dexamethasone suspension 9% compared to standard of care topical regimen for #CataractSurgery. WATCH the full interview: https://t.co/PQa1b6vSNm #Ophthalmology #Cataract @EyeInstituteWFL #ASCRS2021 @EyePointPharma https://t.co/WWJtgyAVhC
-
-
Mashup Score: 2Evaluating risuteganib for dry eye disease treatment - 3 year(s) ago
Eric Donnenfeld, MD, of Ophthalmic Consultants of Long Island (Garden City, NY), discusses highlights from his presentation of trial results analyzing risuteganib as a potential treatment for dry eye disease. Read more about the trial results here
Source: Ophthalmology TimesCategories: Latest Headlines, OphthalmologyTweet
-
Mashup Score: 6Case report: Intermediate uveitis caused by black ink tattoo - 3 year(s) ago
Jonathan D. Shader, DO, CPA, presents a case study involving an uncommon cause of posterior-intermediate uveitis: the black ink used to create a tattoo.
Source: Ophthalmology TimesCategories: Latest Headlines, OphthalmologyTweet
WATCH: Mitch Shultz, MD, speaks on the capabilities of a cloud-based database system to look at energy-fluid metrics, allow surgeons to refine procedures, and provide better patient outcomes. #ASCRS2021 https://t.co/7LkjN6yA4t #Ophthalmology #ASCRS @BauschLomb https://t.co/V8TqVPfayU